Division of Breast Imaging, Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA, 02115, USA.
Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Breast Cancer Res Treat. 2024 Feb;203(3):511-521. doi: 10.1007/s10549-023-07155-z. Epub 2023 Nov 10.
Axillary lymph nodes (LNs) with cortical thickness > 3 mm have a higher likelihood of malignancy. To examine the positive predictive value (PPV) of axillary LN cortical thickness in newly diagnosed breast cancer patients, and nodal, clinical, and tumor characteristics associated with axillary LN metastasis.
Retrospective review of axillary LN fine needle aspirations (FNAs) performed 1/1/2018-12/31/2019 included 135 axillary FNAs in 134 patients who underwent axillary surgery. Patient demographics, clinical characteristics, histopathology, and imaging features were obtained from medical records. Hypothesis testing was performed to identify predictors of axillary LN metastasis.
Cytology was positive in 72/135 (53.3%), negative in 61/135 (45.2%), and non-diagnostic in 2/135 (1.5%). At surgery, histopathology was positive in 84 (62.2%) and negative in 51 (37.8%). LN cortices were thicker in metastatic compared to negative nodes (p < 0.0001). PPV of axillary LNs with cortical thickness ≥ 3 mm, ≥ 3.5 mm, ≥ 4 mm and, ≥ 4.25 mm was 0.62 [95% CI 0.53, 0.70], 0.63 [0.54, 0.72], 0.67 [0.57, 0.76] , and 0.74 [0.64, 0.83], respectively. At multivariable analysis, abnormal hilum (OR = 3.44, p = 0.016) and diffuse cortical thickening (OR = 2.86, p = 0.038) were associated with nodal metastasis.
In newly diagnosed breast cancer patients, increasing axillary LN cortical thickness, abnormal fatty hilum, and diffuse cortical thickening are associated with nodal metastasis. PPV of axillary LN cortical thickness ≥ 3 mm and ≥ 3.5 mm is similar but increases for cortical thickness ≥ 4 mm. FNA of axillary LNs with cortex < 4 mm may be unnecessary for some patients undergoing sentinel LN biopsy.
皮质厚度>3 毫米的腋窝淋巴结(LNs)更有可能发生恶性肿瘤。为了研究新诊断乳腺癌患者腋窝淋巴结皮质厚度的阳性预测值(PPV),以及与腋窝淋巴结转移相关的淋巴结、临床和肿瘤特征。
回顾性分析 2018 年 1 月 1 日至 2019 年 12 月 31 日期间进行的腋窝淋巴结细针抽吸(FNAs),包括 134 例接受腋窝手术的患者中的 135 例腋窝 FNAs。从病历中获取患者人口统计学、临床特征、组织病理学和影像学特征。通过假设检验来确定腋窝淋巴结转移的预测因素。
细胞学检查阳性 72/135(53.3%),阴性 61/135(45.2%),非诊断性 2/135(1.5%)。手术时,组织病理学阳性 84 例(62.2%),阴性 51 例(37.8%)。转移性淋巴结的皮质比阴性淋巴结更厚(p<0.0001)。皮质厚度≥3 毫米、≥3.5 毫米、≥4 毫米和≥4.25 毫米的腋窝淋巴结的 PPV 分别为 0.62[95%CI 0.53,0.70]、0.63[0.54,0.72]、0.67[0.57,0.76]和 0.74[0.64,0.83]。多变量分析显示,异常门部(OR=3.44,p=0.016)和弥漫性皮质增厚(OR=2.86,p=0.038)与淋巴结转移相关。
在新诊断的乳腺癌患者中,腋窝淋巴结皮质厚度增加、异常脂肪门部和弥漫性皮质增厚与淋巴结转移有关。皮质厚度≥3 毫米和≥3.5 毫米的腋窝淋巴结的 PPV 相似,但皮质厚度≥4 毫米时会增加。对于一些接受前哨淋巴结活检的患者,皮质厚度<4 毫米的腋窝淋巴结的细针抽吸可能是不必要的。